Tumor lysis syndrome epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Mahshid)
 
(4 intermediate revisions by one other user not shown)
Line 4: Line 4:
==Overview==
==Overview==
The exact incidence of tumor lysis syndrome has not been established. There is no racial or sex predilection for tumor lysis syndrome.<ref name="pmid15604606">{{cite journal| author=Locatelli F, Rossi F| title=Incidence and pathogenesis of tumor lysis syndrome. | journal=Contrib Nephrol | year= 2005 | volume= 147 | issue=  | pages= 61-8 | pmid=15604606 | doi=10.1159/000082543 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15604606  }} </ref>
The exact incidence of tumor lysis syndrome has not been established. There is no racial or sex predilection for tumor lysis syndrome.<ref name="pmid15604606">{{cite journal| author=Locatelli F, Rossi F| title=Incidence and pathogenesis of tumor lysis syndrome. | journal=Contrib Nephrol | year= 2005 | volume= 147 | issue=  | pages= 61-8 | pmid=15604606 | doi=10.1159/000082543 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15604606  }} </ref>
 
==Epidemiology and Demographics==
==Incidence==
===Incidence===
The exact incidence of tumor lysis syndrome has not been established. <ref name="pmid15604606">{{cite journal| author=Locatelli F, Rossi F| title=Incidence and pathogenesis of tumor lysis syndrome. | journal=Contrib Nephrol | year= 2005 | volume= 147 | issue=  | pages= 61-8 | pmid=15604606 | doi=10.1159/000082543 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15604606  }} </ref>
The exact incidence of tumor lysis syndrome has not been established.<ref name="pmid15604606">{{cite journal| author=Locatelli F, Rossi F| title=Incidence and pathogenesis of tumor lysis syndrome. | journal=Contrib Nephrol | year= 2005 | volume= 147 | issue=  | pages= 61-8 | pmid=15604606 | doi=10.1159/000082543 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15604606  }} </ref>
==Age and Race==
===Race===
There is no racial or sex prediction for tumor lysis syndrome.<ref name="pmid15604606">{{cite journal| author=Locatelli F, Rossi F| title=Incidence and pathogenesis of tumor lysis syndrome. | journal=Contrib Nephrol | year= 2005 | volume= 147 | issue=  | pages= 61-8 | pmid=15604606 | doi=10.1159/000082543 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15604606  }} </ref>
There is no racial prediction for tumor lysis syndrome.<ref name="pmid15604606">{{cite journal| author=Locatelli F, Rossi F| title=Incidence and pathogenesis of tumor lysis syndrome. | journal=Contrib Nephrol | year= 2005 | volume= 147 | issue=  | pages= 61-8 | pmid=15604606 | doi=10.1159/000082543 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15604606  }} </ref>
===Gender===
There is no sex prediction for tumor lysis syndrome.<ref name="pmid15604606">{{cite journal| author=Locatelli F, Rossi F| title=Incidence and pathogenesis of tumor lysis syndrome. | journal=Contrib Nephrol | year= 2005 | volume= 147 | issue=  | pages= 61-8 | pmid=15604606 | doi=10.1159/000082543 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15604606  }} </ref>


==References==
==References==
Line 19: Line 21:
[[Category:Blood]]
[[Category:Blood]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]

Latest revision as of 17:25, 27 November 2017

Tumor lysis syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tumor lysis syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tumor lysis syndrome epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tumor lysis syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tumor lysis syndrome epidemiology and demographics

CDC on Tumor lysis syndrome epidemiology and demographics

Tumor lysis syndrome epidemiology and demographics in the news

Blogs on Tumor lysis syndrome epidemiology and demographics

Directions to Hospitals Treating Tumor lysis syndrome

Risk calculators and risk factors for Tumor lysis syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

The exact incidence of tumor lysis syndrome has not been established. There is no racial or sex predilection for tumor lysis syndrome.[1]

Epidemiology and Demographics

Incidence

The exact incidence of tumor lysis syndrome has not been established.[1]

Race

There is no racial prediction for tumor lysis syndrome.[1]

Gender

There is no sex prediction for tumor lysis syndrome.[1]

References

  1. 1.0 1.1 1.2 1.3 Locatelli F, Rossi F (2005). "Incidence and pathogenesis of tumor lysis syndrome". Contrib Nephrol. 147: 61–8. doi:10.1159/000082543. PMID 15604606.

Template:WH Template:WS